Position in EXEL
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,917
+$3,915 QoQ
Shares Held
72
+26.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#697
of 751 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Navigoe, LLC holds $17,913 across 27 Biotechnology names. EXEL ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELDN |
Eledon Pharmaceuticals, Inc.
|
1,005 | $3,959 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
72 | $3,917 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7 | $3,477 | |
| 4 | INCY |
Incyte Corp
|
8 | $906 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
24 | $849 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
3 | $722 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
8 | $626 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
10 | $572 |
All Filings in EXEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,917 | 72 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $2 | 57 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2 | 57 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2 | 57 | Shares | Sole | 2025-10-10 | |
| No filing history on record for this holder in this stock. | ||||||